Bert A van der Reijden

17PUBLICATIONS
82CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Medical mycologyHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 25, 2026
Comprehensive lincRNA Transcriptome in Acute Myeloid Leukemia: Integrating Known and Newly Identified lincRNAs Across Pediatric and Adult Cohorts.

|Dec 15, 2025
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.

Jacqueline Cloos, Peter J M Valk, Christian Thiede

|Dec 05, 2024
HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia.

Saioa Arza-Apalategi, Branco M H Heuts, Saskia M Bergevoet

|Mar 29, 2024
GFI1B and LSD1 repress myeloid traits during megakaryocyte differentiation.

Jeron Venhuizen, Maaike G J M van Bergen, Saskia M Bergevoet

|Feb 15, 2024
Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses.

Jeppe F Severens, E Onur Karakaslar, Bert A van der Reijden

|Sep 21, 2023
BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient population.

Camille Kockerols, Peter J M Valk, Nicole M A Blijlevens

Pageof 3

Frequent Collaborators

4 joint publications

Daan Gilissen

3 joint publications

Nicole M A Blijlevens

3 joint publications

Saioa Arza-Apalategi

3 joint publications

Isabelle A van Zeventer